illumigyn, a remote gynecological imaging platform, today announced that it has raised a total of $33 million following the closure of its latest investment round. The current round includes participation from the Yozma Group Korea and Ubicom Holdings Japan, and it will help the company deploy its platform this month in the United States, United Arab Emirates, India, Singapore, and South Korea.
illumigyn has developed a platform featuring the Gynescope System, a “gynecology endoscope” and cloud platform service with an accompanying mobile app that can digitally document the cervix, vagina, and external gentiles and help achieve more accurate pap smears. It can be handled by any trained caregiver so that women can be assessed safely. It is an FDA-cleared platform and the HIPAA-compliant solution automatically uploads and stores images to the cloud, allowing doctors or specialists to view them remotely.
“This is another milestone in our vision to democratize women’s healthcare and bring advanced gynecological care to women worldwide,” said Ran Poliakine, illumigyn’s Founder. “Our deployments this month are aligned with our mission to bring our platform to women everywhere, in developed and developing countries, in population centers, as well as remote communities. This is our mission and our commitment.”
The investment will support R&D efforts for the company geared towards providing women across the world the best care for cancers and other diseases. It includes the availability of preventive screenings, evaluations, diagnoses, and treatments.
“We are proud to introduce to the world a cutting-edge innovation that will ensure that women all over the world will feel safe during gynecological exams and will have access to all of their medical information,” added Dr. Avi Ludomirski, CEO and Chairman of the Board of illumigyn.“The funding secured by the company will be deployed to ramp up production and will enable illumigyn to execute existing distribution agreements and sign additional new global partnerships.”
Wonjae Lee, Head of Asia Pacific of the Yozma Group, said how the company has a “novel mission to bridge the gap between all women and outstanding healthcare, and empowering women with state of the art, proprietary technology. Our investment comes after our impressive discussions with the company’s leaders, whose vision is not only valuable in this current moment post-pandemic but is sure to shape the future of gynecology and how women can continue to access innovative and intelligent healthcare.”
illumigyn was founded in 2012 by Ran Poliakine and Lior Greenstein and helps make women’s health accessible and affordable around the world. The Yozma Group is an Israeli VC firm founded in 1993 that typically invests in healthcare and medical technologies. The Yozma Group Korea was founded in 2015.